Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

"nIntroduction: Infections in neutropenic patients are considered as major causes of mortality and emergence of drug resistant Gram positive bacterial infections are crucially important to be covered if indicated. Vancomycin is active against most Gram positive bacteria including methicilli...

Full description

Bibliographic Details
Main Authors: Alireza Hayatshahi, Mohammadreza Javadi, Hassan Torkamandi, Molouk Hadjibabaie, Sara Alahyari, Kheirollah Gholami, Kamran Alimoghaddam, Masoud Iravani, Ardeshir Ghavamzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-07-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18604.pdf&manuscript_id=18604
_version_ 1827842995864469504
author Alireza Hayatshahi
Mohammadreza Javadi
Hassan Torkamandi
Molouk Hadjibabaie
Sara Alahyari
Kheirollah Gholami
Kamran Alimoghaddam
Masoud Iravani
Ardeshir Ghavamzadeh
author_facet Alireza Hayatshahi
Mohammadreza Javadi
Hassan Torkamandi
Molouk Hadjibabaie
Sara Alahyari
Kheirollah Gholami
Kamran Alimoghaddam
Masoud Iravani
Ardeshir Ghavamzadeh
author_sort Alireza Hayatshahi
collection DOAJ
description "nIntroduction: Infections in neutropenic patients are considered as major causes of mortality and emergence of drug resistant Gram positive bacterial infections are crucially important to be covered if indicated. Vancomycin is active against most Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA). In this study, we evaluated the appropriate utilization of this agent. "nMethods: We conducted a prospective observational study at bone marrow transplantation research center, Shariati teaching hospital in Tehran to evaluate the appropriateness of vancomycin utilization for our adult bone marrow transplantation (BMT) patients for a period of six months. "nResults: The charts of a total of 117 patients were prospectively reviewed in 3 adult BMT wards. Seventy four patients (63.2%) received vancomycin treatment during their hospital stay. Most patients received allogienic versus autologous transplantation (62.2%, 18.9%). Majority of patients were under 50 years of age (91.9%). About 58% of cases were febrile neutropenic at the time of vancomycin initiation. Based on the criteria of appropriate indications, vancomycin utilization was justified in 59.5% of cases which 43.2% of those cases received appropriate initial doses. "nConclusion: Based on the results of this study, in the majority of our BMT patients vancomycin was utilized appropriately as a part of their empiric treatment. More attention in the time of initiation and also dose adjustment seems to be necessary to minimize treatment failure and the emergence of drug resistance.
first_indexed 2024-03-12T08:18:23Z
format Article
id doaj.art-fea2321d49fe4138aa262e5908b77bd2
institution Directory Open Access Journal
issn 2008-3009
2008-2207
language English
last_indexed 2024-03-12T08:18:23Z
publishDate 2010-07-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-fea2321d49fe4138aa262e5908b77bd22023-09-02T18:40:48ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072010-07-01431013Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation CenterAlireza HayatshahiMohammadreza JavadiHassan TorkamandiMolouk HadjibabaieSara AlahyariKheirollah GholamiKamran AlimoghaddamMasoud IravaniArdeshir Ghavamzadeh"nIntroduction: Infections in neutropenic patients are considered as major causes of mortality and emergence of drug resistant Gram positive bacterial infections are crucially important to be covered if indicated. Vancomycin is active against most Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA). In this study, we evaluated the appropriate utilization of this agent. "nMethods: We conducted a prospective observational study at bone marrow transplantation research center, Shariati teaching hospital in Tehran to evaluate the appropriateness of vancomycin utilization for our adult bone marrow transplantation (BMT) patients for a period of six months. "nResults: The charts of a total of 117 patients were prospectively reviewed in 3 adult BMT wards. Seventy four patients (63.2%) received vancomycin treatment during their hospital stay. Most patients received allogienic versus autologous transplantation (62.2%, 18.9%). Majority of patients were under 50 years of age (91.9%). About 58% of cases were febrile neutropenic at the time of vancomycin initiation. Based on the criteria of appropriate indications, vancomycin utilization was justified in 59.5% of cases which 43.2% of those cases received appropriate initial doses. "nConclusion: Based on the results of this study, in the majority of our BMT patients vancomycin was utilized appropriately as a part of their empiric treatment. More attention in the time of initiation and also dose adjustment seems to be necessary to minimize treatment failure and the emergence of drug resistance.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18604.pdf&manuscript_id=18604 VancomycinFebrile NeutropenicEmpiric TreatmentGram positive infection
spellingShingle Alireza Hayatshahi
Mohammadreza Javadi
Hassan Torkamandi
Molouk Hadjibabaie
Sara Alahyari
Kheirollah Gholami
Kamran Alimoghaddam
Masoud Iravani
Ardeshir Ghavamzadeh
Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
International Journal of Hematology-Oncology and Stem Cell Research
Vancomycin
Febrile Neutropenic
Empiric Treatment
Gram positive infection
title Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
title_full Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
title_fullStr Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
title_full_unstemmed Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
title_short Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center
title_sort drug utilization review of vancomycin in febrile neutropenic patients hospitalized at a bone marrow transplantation center
topic Vancomycin
Febrile Neutropenic
Empiric Treatment
Gram positive infection
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18604.pdf&manuscript_id=18604
work_keys_str_mv AT alirezahayatshahi drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT mohammadrezajavadi drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT hassantorkamandi drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT moloukhadjibabaie drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT saraalahyari drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT kheirollahgholami drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT kamranalimoghaddam drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT masoudiravani drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter
AT ardeshirghavamzadeh drugutilizationreviewofvancomycininfebrileneutropenicpatientshospitalizedatabonemarrowtransplantationcenter